Journey Began in 1999 as Obsurge Pharma Pvt Ltd which later transpired to Obsurge Biotech Ltd. in January 2002 with presence in various healthcare verticals. All our products are Tested for various parameters even post expiry.
In Brief
Trusted brands – SERADIC Range, DUB & ANXISET in the Indian Market for more than 15 years.
Working with sole motto of “Quality Healthcare with Technological excellence in India & South East Asia. .
Cater to General Physicians, Ophthalmology, Urology, cardiology, Dentistry, ENT, Orthopedics, Gastroenterology, Dermatology, Neurology, Surgeons and Gynecology.
Team of 500+ Trained Sales and Marketing Personnel's and about 50 Area/Regional Managers.
WHO:GMP approved Manufacturing at Roorkee, India (Sister Concern UNICURE , India) & through other EU:GMP approved & WHO:GMP approved 3rd Party Contract sites.
Journey so far..
1999
Inception Year
2004
Expanded to 10 States
2008
Expansion to 15 states
2013
Entered Urology, Cardiac & Diabetic segment with 15 products
2012
NACTAB Launched
2011
ANXISET Plus launched
2014
ANXISET approved by THAI market
2015
New ACTDs filed In THAILAND & YEMEN
2017
More than 10 brands listed in Martindale
2022
Emestat Range expanded with Em-24 (First Time in India & Ortho basket made strong with Seradic-Joints (A patented formulation for OA)
2021
Entry into Critical Care product with launch of FAVISURGE
2019
ANXISET became No.1 Brand in Thailand
1999
Inception Year
2004
Expanded to 10 States
2008
Expansion to 15 states
2011
ANXISET Plus launched
2012
NACTABLaunched
2013
Entered Urology, Cardiac & Diabetic segment with 15 products
2014
ANXISET approved by THAI market
2015
New ACTDs filed In THAILAND & YEMEN
2017
More than 10 brands listed in Martindale
2019
ANXISET became No.1 Brand in Thailand
2021
Entry into Critical Care product with launch of FAVISURGE
2022
Emestat Range expanded with Em-24 (First Time in India & Ortho basket made strong with Seradic-Joints (A patented formulation for OA)
